Skip to main content
OpenTrials
Completed

NCT Number: NCT03513289

Collaborative Assessment of ICU Recovery Needs

The primary purpose of this study is to better understand the impact of the Society of Critical Care Medicine (SCCM) THRIVE Collaboratives on patients, their families and clinicians.

The investigators have formed an international and interprofessional evaluative team with experts in the field in an effort to explore interactions between survivors and THRIVE. This approach is reflective of the international ethos of SCCM and its collaboratives, with the potential to improve the generalizability of this survivorship research to different health systems.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Australian and New Zealand Intensive Care Research Centre, Melbourne, Victoria, Australia

Loading trial locations.

About this study

The aims of this qualitative study are:

  • To identify elements that helped survivors in their recovery, as well as potential obstacles
  • To capture elements of survivorshop that are generalizable, regardless of participation in the THRIVE collaboratives
  • To gain knowledge to be incorporated back into the collaboratives

Patients, family members, and clinicians will be interviewed and their responses analyzed for themes of ICU recovery including elements that patients and families find helpful to recovery, barriers and facilitators to different models of post-ICU support, including peer support and post-ICU clinics, and drivers of improvement in post-ICU care. Patients, carers, and clinicians with a wide variety of survivorship experiences are encouraged to participate, including those who have participated in a THRIVE collaborative support site (peer support or clinic).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who survived a critical illness, and their carers, who were identified by collaborative members or self-identify as having been through a THRIVE Program.
  • Patients who survived a critical illness, and their carers, who did not participate in a THRIVE program.
  • Clinicians directly involved in the care of ICU survivors in the outpatient setting, who have participated in a THRIVE initiative through the Society of Critical Care Medicine.

Exclusion criteria

  • N/A

Treatment and study plan

Patient, Carer, and Clinician Interviews

Other

Post-ICU follow-up interviews conducted over the phone, lasting between 30-60 minutes.

Primary outcomes

  1. Survivorship Experiences from Patients

    Time frame: 18 months

    30-minute audio-taped, semi-structured interviews with patients informing on post-ICU care coordination

Secondary outcomes

  1. Survivorship Experiences from Caregivers

    Time frame: 18 months

    30-minute audio-taped, semi-structured interviews with caregivers informing on post-ICU care coordination

  2. Survivorship Experiences from Clinicians

    Time frame: 18 months

    30-minute audio-taped, semi-structured interviews with clinicians informing on post-ICU care coordination

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Collaborators

  • Society of Critical Care Medicine

Registry information

Acronym: CAIRN

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
May 1, 2018
Registry last updated
Feb 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.